MOH Quote, Financials, Valuation and Earnings

Centene has a net margin of 3.15% compared to Molina Healthcare's net margin of 1.7%. Molina Healthcare's return on equity of 25.77% beat Centene's return on equity of 11.5%.

Molina Healthcare has a consensus price target of $360.77, signalling upside risk potential of 22.64%. On the other hand Centene has an analysts' consensus of $79.39 which suggests that it could grow by 31.01%. Given that Centene has higher upside potential than Molina Healthcare, analysts believe Centene is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.536, which suggesting that the stock is 46.386% less volatile than S&P 500. In comparison Centene has a beta of 0.457, suggesting its less volatile than the S&P 500 by 54.321%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Molina Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Centene quarterly revenues of $42B. Molina Healthcare's net income of $326M is lower than Centene's net income of $713M. Notably, Molina Healthcare's price-to-earnings ratio is 14.94x while Centene's PE ratio is 10.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 3.15% compared to Molina Healthcare's net margin of 2.25%. Molina Healthcare's return on equity of 25.77% beat Elevance Health's return on equity of 15.67%.

Molina Healthcare has a consensus price target of $360.77, signalling upside risk potential of 22.64%. On the other hand Elevance Health has an analysts' consensus of $505.44 which suggests that it could grow by 36.21%. Given that Elevance Health has higher upside potential than Molina Healthcare, analysts believe Elevance Health is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.536, which suggesting that the stock is 46.386% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.828, suggesting its less volatile than the S&P 500 by 17.228%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.76% to investors and pays a quarterly dividend of $1.63 per share. Molina Healthcare pays -- of its earnings as a dividend. Elevance Health pays out 23.3% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Elevance Health quarterly revenues of $45.1B. Molina Healthcare's net income of $326M is lower than Elevance Health's net income of $1B. Notably, Molina Healthcare's price-to-earnings ratio is 14.94x while Elevance Health's PE ratio is 13.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.50x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Humana has a net margin of 3.15% compared to Molina Healthcare's net margin of 1.63%. Molina Healthcare's return on equity of 25.77% beat Humana's return on equity of 8.1%.

Molina Healthcare has a consensus price target of $360.77, signalling upside risk potential of 22.64%. On the other hand Humana has an analysts' consensus of $287.90 which suggests that it could grow by 12.62%. Given that Molina Healthcare has higher upside potential than Humana, analysts believe Molina Healthcare is more attractive than Humana.

Molina Healthcare has a beta of 0.536, which suggesting that the stock is 46.386% less volatile than S&P 500. In comparison Humana has a beta of 0.532, suggesting its less volatile than the S&P 500 by 46.758%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.39% to investors and pays a quarterly dividend of $0.89 per share. Molina Healthcare pays -- of its earnings as a dividend. Humana pays out 17.32% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than Humana quarterly revenues of $29.4B. Molina Healthcare's net income of $326M is lower than Humana's net income of $480M. Notably, Molina Healthcare's price-to-earnings ratio is 14.94x while Humana's PE ratio is 22.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 0.27x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of 3.15% compared to Molina Healthcare's net margin of 6.11%. Molina Healthcare's return on equity of 25.77% beat UnitedHealth Group's return on equity of 14.51%.

Molina Healthcare has a consensus price target of $360.77, signalling upside risk potential of 22.64%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 24.44%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

Molina Healthcare has a beta of 0.536, which suggesting that the stock is 46.386% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.

Molina Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Molina Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Molina Healthcare quarterly revenues are $10.3B, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Molina Healthcare's net income of $326M is lower than UnitedHealth Group's net income of $6.1B. Notably, Molina Healthcare's price-to-earnings ratio is 14.94x while UnitedHealth Group's PE ratio is 33.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Molina Healthcare is 0.44x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.